Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2534724 | chr12:6583387 | C/T | 0.000269 | 178 | 19.3 | 25.97 | 25.42 | KM Plot |
PCPG | rs2564926 | chr3:53094730 | G/A | 6.03E-6 | 176 | 11.78 | 26.05 | 25.53 | KM Plot |
PCPG | rs2581807 | chr3:53088844 | G/A | 5.82E-6 | 176 | 11.78 | 22.83 | 25.77 | KM Plot |
PCPG | rs2593823 | chr3:108533289 | C/A | 5.6E-5 | 174 | 25.53 | 20.3 | 2.93 | KM Plot |
PCPG | rs2603382 | chr2:52993247 | C/T | 0 | 175 | 25.4 | 24.5 | 3.17 | KM Plot |
PCPG | rs2657407 | chr7:158782543 | T/C | 3.54E-5 | 172 | 3.17 | 24.7 | 25.77 | KM Plot |
PCPG | rs2669893 | chr13:37636740 | G/A | 0.000354 | 174 | 3.55 | 22.22 | 26.88 | KM Plot |
PCPG | rs2676610 | chr17:3222813 | T/C | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs2676612 | chr17:3225404 | C/T | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs2679046 | chr3:81005437 | G/A | 0.000193 | 173 | 25.87 | 23.53 | 25.17 | KM Plot |
PCPG | rs2687792 | chr3:182468750 | A/T | 1.47E-7 | 173 | 11.78 | 27.83 | 25.53 | KM Plot |
PCPG | rs2700852 | chr3:182473750 | A/G | 1.19E-5 | 174 | 13.27 | 25.85 | 25.53 | KM Plot |
PCPG | rs2700853 | chr3:182475939 | T/G | 1.22E-5 | 173 | 13.27 | 27.2 | 25.53 | KM Plot |
PCPG | rs27012 | chr5:179402211 | A/C | 0.000251 | 175 | 24.1 | 32.53 | 14.83 | KM Plot |
PCPG | rs27018 | chr5:179405144 | A/G | 0.000242 | 176 | 23.82 | 32.53 | 14.83 | KM Plot |